Vascular Disrupting Agents (VDAs) in Anticancer Therapy

E-ISSN： 2212-3938|5|3|178-185

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 178-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular-disrupting agents in oncology

By Mita Monica M Sargsyan Liza Mita Alain C Spear Matt

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 317-328

Informa Healthcare

Access to resources Recommend Favorite

Tumour targeting by microtubule-depolymerising vascular disrupting agents

By Kanthou Chryso Tozer Gillian M

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1443-1457

Informa Healthcare

Access to resources Recommend Favorite

New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 1039-1049

Bentham Science Publishers

Access to resources Recommend Favorite

Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

Current Medicinal Chemistry, Vol. 22, Iss. 11, 2015-04 ,pp. : 1348-1360

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer

Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-01 ,pp. : 3919-3930

Bentham Science Publishers

Access to resources Recommend Favorite